However, the haplotype IL10 -1082, -819, and -592 ACC was more frequent in controls compared to DLBCL patients (OR: 0.55, P = 0.03; compared to the ATA haplotype), and it was less frequent in patients treated with R-CHOP with complete remission of disease compared to patients who died or had recurrence or progression of the disease to progress to death (OR: 2.83, P = 0.03; compared to the ATA haplotype). The gene discussed is IL10; the disease is diffuse large B-cell lymphoma.